Skip Nav Destination
Issues
June 2016
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 0001-5792
EISSN 1421-9662
In this Issue
Acta Haematologica 2016, Vol. 136, No. 1
Review
Practical Management of Castleman's Disease
Acta Haematol (2016) 136 (1): 16–22.
https://doi.org/10.1159/000444515
Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis
Sue Harnan; Shiji Ren; Tim Gomersall; Emma S. Everson-Hock; Anthea Sutton; Sujith Dhanasiri; Austin Kulasekararaj
Acta Haematol (2016) 136 (1): 23–42.
https://doi.org/10.1159/000445163
Editorial Comment
Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead
Acta Haematol (2016) 136 (1): 43–44.
https://doi.org/10.1159/000445674
Original Paper
Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response
Fiorenzo Santoleri; Ruggero Lasala; Elena Ranucci; Gaetano La Barba; Roberto Di Lorenzo; Antonio Vetrò; Paolo Di Bartolomeo; Alberto Costantini
Acta Haematol (2016) 136 (1): 45–51.
https://doi.org/10.1159/000444626
Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma
Antica Duletić-Načinović; Vedrana Gačić; Toni Valković; Ksenija Lučin; Elizabeta Fišić; Marta Žuvić-Butorac; Irena Seili-Bekafigo; Nives Jonjić
Acta Haematol (2016) 136 (1): 52–61.
https://doi.org/10.1159/000444624
Brief Communication
Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients
Jaspal Kaeda; Frauke Ringel; Christian Oberender; Martin Gresse; Leila Amini; Michaela Schwarz; Bernd Dörken; Philipp le Coutre
Acta Haematol (2016) 136 (1): 62–64.
https://doi.org/10.1159/000445097
